Our mission
From reactive scans to proactive peace of mind.
Mammoptix exists to help women feel informed and in control of their breast-implant health, long after surgery.
Mammoptix was founded by Michel Van Cauwenbergh after years spent working in the breast-implant industry, where the same gap appeared again and again:
Â
once a woman leaves the clinic, there is very little to reassure her until her next appointment.
Â
Mammoptix is our answer, a way to bring continuous, at-home monitoring to millions of women.
The story
Our values
Women first
We build around real needs, comfort and trust.
Honest science
We are transparent about what we know and what we are still proving.
Care, continued
We stay present in the journey, not just at the operating table.
Team and advisors
Founder and CEO
Michel Van Cauwenbergh
Prof. Andy Adler
Impedance measurement, Carleton University
Dr. Kristoff Verdonck
Plastic surgery
Dr. Fatima Ahankour
OB-GYN, breast health
Prof. Ronald Thoelen
Biomedical engineering, UHasselt.
Partners and support
Mammoptix is developed with university and industry partners and supported by European and Flemish government innovation funding (VLAIO).
Partner logos placeholder
Join us
We are a growing team. If you care about women's health and want to help build something meaningful, get in touch.